Cargando…

Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17

BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Justin C., Roman-Urrestarazu, Andres, Brayne, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907755/
https://www.ncbi.nlm.nih.gov/pubmed/31830137
http://dx.doi.org/10.1371/journal.pone.0226349
_version_ 1783478589305389056
author Yang, Justin C.
Roman-Urrestarazu, Andres
Brayne, Carol
author_facet Yang, Justin C.
Roman-Urrestarazu, Andres
Brayne, Carol
author_sort Yang, Justin C.
collection PubMed
description BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. METHODS: We draw upon data from the Treatment Episode Data Set—Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. RESULTS: Estimates from logistic regression models highlight certain groups which show lower odds of receipt of OAT, including those in precarious housing arrangements, those unemployed or not otherwise in the labor force, and those referred by drug abuse care providers, educational institutions, employers, and the criminal justice system. Groups which showed higher odds of waiting over a week to enter treatment included those who were separated, divorced, or widowed, those working part-time, and those referred by drug abuse care providers, employers, and the criminal justice system. CONCLUSION: Given the efficacy of OAT and the adverse outcomes associated with long waiting times, coordinated effort is needed to understand why these differences persist and how they may be addressed through appropriate policy responses.
format Online
Article
Text
id pubmed-6907755
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69077552019-12-27 Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 Yang, Justin C. Roman-Urrestarazu, Andres Brayne, Carol PLoS One Research Article BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. METHODS: We draw upon data from the Treatment Episode Data Set—Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. RESULTS: Estimates from logistic regression models highlight certain groups which show lower odds of receipt of OAT, including those in precarious housing arrangements, those unemployed or not otherwise in the labor force, and those referred by drug abuse care providers, educational institutions, employers, and the criminal justice system. Groups which showed higher odds of waiting over a week to enter treatment included those who were separated, divorced, or widowed, those working part-time, and those referred by drug abuse care providers, employers, and the criminal justice system. CONCLUSION: Given the efficacy of OAT and the adverse outcomes associated with long waiting times, coordinated effort is needed to understand why these differences persist and how they may be addressed through appropriate policy responses. Public Library of Science 2019-12-12 /pmc/articles/PMC6907755/ /pubmed/31830137 http://dx.doi.org/10.1371/journal.pone.0226349 Text en © 2019 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yang, Justin C.
Roman-Urrestarazu, Andres
Brayne, Carol
Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
title Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
title_full Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
title_fullStr Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
title_full_unstemmed Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
title_short Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
title_sort differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the united states, 2014-17
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907755/
https://www.ncbi.nlm.nih.gov/pubmed/31830137
http://dx.doi.org/10.1371/journal.pone.0226349
work_keys_str_mv AT yangjustinc differencesinreceiptofopioidagonisttreatmentandtimetoentertreatmentforopioidusedisorderamongspecialtyaddictionprogramsintheunitedstates201417
AT romanurrestarazuandres differencesinreceiptofopioidagonisttreatmentandtimetoentertreatmentforopioidusedisorderamongspecialtyaddictionprogramsintheunitedstates201417
AT braynecarol differencesinreceiptofopioidagonisttreatmentandtimetoentertreatmentforopioidusedisorderamongspecialtyaddictionprogramsintheunitedstates201417